News and Stories About FDA
Lynparza Approved for Pancreatic Cancer Patients Identified by Testing
Dec 30, 2019
Today the U.S. Food and Drug Administration (FDA) approved the targeted therapy Lynparza® (olaparib) for the treatment of patients who […]
READ MORE
FDA Hosts Patient Advocacy Leaders
Oct 10, 2019
Patient advocacy leaders, including Pancreatic Cancer Action Network’s (PanCAN) chief medical officer Victoria Manax, MD, gave opening remarks at the […]
READ MORE
